Anika Therapeutics reported $9.18M in Operating Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US $ 1342M 767M
Acceleron Pharma XLRN:US $ -63.66M 0.06M
Acorda Therapeutics ACOR:US $ -15.69M 13.09M
Adamas Pharmaceuticals ADMS:US -9155000 370K
Agenus AGEN:US $ -66.4M 25.02M
Agios Pharmaceuticals AGIO:US $ -89.22M 2M
Anika Therapeutics ANIK:US $ 9.18M 7.92M
Arrowhead Research ARWR:US $ -31868000 3.64M
Chemocentryx CCXI:US $ -38.74M 9.41M
Clovis Oncology CLVS:US $ -57.58M 0.43M
Dicerna Pharmaceuticals DRNA:US $ -40.24M 11.14M
Enanta Pharmaceuticals ENTA:US $ -33.85M 4.15M
Flexion Therapeutics FLXN:US $ -16882000 6.26M
Halozyme Therapeutics HALO:US $ 93.05M 63.27M
Heron Therapeutics HRTX:US $ -60.47M 8.36M
Immunogen IMGN:US $ -27.37M 1.55M
Insmed INSM:US $ -106255000 22.42M
Integra Lifesciences IART:US $ 51.85M 19.55M
Intrexon XON:US $ -15.67M 2.01M
Johnson & Johnson JNJ:US $ 6662M 767M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Ligand Pharmaceuticals LGND:US $ 45.74M 45.82M
Macrogenics MGNX:US $ -40279000 11.01M
Merit Medical Systems MMSI:US $ 8.9M 5.3M
Peregrine Pharmaceuticals PPHM:US $ 6.93M 3.84M
Rigel Pharmaceuticals RIGL:US $ -13.05M 54.8M
Sangamo Biosciences SGMO:US $ -48.7M 2.4M
Stryker SYK:US $ 729M 259M
Surmodics SRDX:US $ -2.38M 11.87M
Veracyte VCYT:US $ -7.47M 37.94M
Xencor XNCR:US $ 9.09M 24.76M
Zimmer Biomet Holdings Inc ZBH:US $ 220.5M 45.1M